Search filters

List of works by Katja Sockel

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine ⬇️

scholarly article

A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients

scientific article published on 08 November 2018

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse

scientific article published in 2022

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry

Anti-CD123 Targeted Therapy with Talacotuzumab in Advanced MDS and AML after Failing Hypomethylating Agents - Final Results of the Samba Trial ⬇️

scholarly article

Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial

scientific article published on 12 March 2018

Anticoagulation with direct factor Xa inhibitors in transplant recipients: Results from the DRESDEN NOAC REGISTRY (NCT01588119)

scientific article published on 25 April 2020

Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)

scientific article published in 2021

Current and Future Treatment Options for Myelodysplastic Syndromes: More Than Hypomethylating Agents and Lenalidomide?

scientific article published on 01 December 2018

Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of <i>TP53</i> mutations - a registry based analysis

scientific article published on 05 January 2021

Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears

scientific article published on 08 September 2021

Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML

scientific article published on 01 June 2022

Discriminant Principal Component Analysis of ToF-SIMS Spectra for Deciphering Compositional Differences of MSC-Secreted Extracellular Matrices

scientific article from 2023

Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)

scientific article published in 2021

H1N1-09 Infections In Patients with Hematologic or Oncologic Malignancies: A Single-Centre Experience ⬇️

scholarly article

Hip Pain in Medulloblastoma as First Symptom of Extraneural Relapse ⬇️

scientific article published on March 23, 2011

Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial

scientific article published in 2020

Impact of pharmacokinetics on the toxicity and efficacy of clofarabine in patients with relapsed or refractory acute myeloid leukemia

scientific article published on 16 May 2017

Induction of short-term remission with single agent eltrombopag in refractory nucleophosmin-1-mutated acute myeloid leukemia

scientific article published on 5 September 2014

Is it already time for combination treatment in lower risk MDS?

scientific article published on 01 December 2012

Lenalidomide maintenance after allogeneic HSCT seems to trigger acute graft-versus-host disease in patients with high-risk myelodysplastic syndromes or acute myeloid leukemia and del(5q): results of the LENAMAINT trial

scientific article published on September 2012

Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial

scientific article published on 17 May 2017

Long-Term Mixed Chimerism After <i>Ex Vivo</i>/<i>In Vivo</i> T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

scientific article published on 07 December 2021

MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation

scientific article published on 18 September 2012

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

scientific article published on 12 November 2018

Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome

scientific article

Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse

scientific article published on 12 July 2011

Molecular Characterization Of The Anti-Leukemic Effects Of Single Agent Eltrombopag ⬇️

scholarly article

Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoring

scientific article published on 25 November 2014

Nanocytometer for smart analysis of peripheral blood and acute myeloid leukemia: a pilot study

scientific article published on 07 August 2020

Optimizing management of myelodysplastic syndromes post-allogeneic transplantation

scientific article published on December 2011

POTENTIAL ROLE of 8-COLOR FLOW CYTOMETRY for CHARACTERIZATION of MDS with Del(5q) ABNORMALITIES ⬇️

scholarly article

Parvovirus B19 Infection

scientific article published on 01 December 2018

Real life experience with alemtuzumab treatment of patients with lower-risk MDS and a hypocellular bone marrow

scientific article published on 10 August 2013

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

scientific article published in 2021

Response and Long-Term Outcome After Treatment With Third-Party Mesenchymal Stromal Cells - Updated Results In 58 Patients With Steroid-Refractory Acute Graft-Versus Host Disease - ⬇️

scholarly article

Retrospective Analysis of Minimal Residual Disease-Guided Preemptive Treatment in Patients with AML and MDS - the SAL Study Group Experience ⬇️

scholarly article

Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents

scientific article published on 03 December 2019

Systemic Iron Overload in Patients Undergoing Allogeneic Stem Cell Transplantation – a Magnetic Resonance Imaging Based Study in 81 AML and MDS Patients ⬇️

scholarly article

Targeting S100A9 in the Inflammatory Myelodysplastic Hematopoietic Niche Reprograms the Functional Properties of CD271+ Mesenchymal Stromal Cells

scientific article published in 2022

Targeting the Inflammatory Niche in MDS By Tasquinimod Restores Hematopoietic Support and Suppresses Immune-Checkpoint Expression <i>in Vitro</i>

scientific article published on 24 November 2021

The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the Prospective PETAML Trial

scientific article published on 29 August 2019

Treating myelodysplastic syndromes by nuclear transport inhibition

scientific article published on 01 August 2020

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients ⬇️

scholarly article

Validation of the Revised Pretransplant Assessment of Mortality Score in Patients with Acute Myelogenous Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

scientific article published on 21 May 2018

When to transplant MDS, and what to do when transplant fails

scientific article published on December 2013

Paulina is supported by:

About Paulina

Help